INS and Impaired glucose tolerance: Since G6Pase catalyzes the final step in gluconeogenesis, reduced levels of G6Pase mRNA could not account for the elevated blood glucose levels seen in A1+/-s, and imply that the abnormal expression of gluconeogenic genes is not relevant to the impaired glucose tolerance and insulin resistance phenotype.